Literature DB >> 12500919

Medical management of osteoid osteoma.

Imran Ilyas1, Derek A Younge.   

Abstract

OBJECTIVE: To see if the results of managing osteoid osteoma with medical treatment alone is comparable to those after surgery or other ablative therapy.
DESIGN: A case series.
SETTING: A tertiary care centre. PATIENTS: Eleven patients with osteoid osteoma treated over a 5-year period. The condition was diagnosed from a typical history, patient age, standard radiography, computed tomography, bone scanning, complete blood count and measurement of the erythrocyte sedimentation rate.
INTERVENTIONS: Continued medical treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) for 6 months after pain ceased. Surgery was done only in those who refused or could not tolerate medical treatment. MAIN
RESULTS: Medical treatment successfully controlled the pain in all patients. Two patients decided to undergo surgery because of intolerance to the NSAIDS. In 7 patients the symptoms resolved after a mean time of 2.5 years. Two patients were still taking NSAIDS 5 years from the time of diagnosis.
CONCLUSIONS: The natural history of osteoid osteoma is self-limited so patients should be offered nonoperative treatment, reserving ablative treatment for those who are unable or unwilling to take NSAIDs until their symptoms resolve.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12500919      PMCID: PMC3684658     

Source DB:  PubMed          Journal:  Can J Surg        ISSN: 0008-428X            Impact factor:   2.089


  19 in total

1.  Medical management of osteoid osteoma.

Authors:  Peter L Munk; Michael E Huk
Journal:  Can J Surg       Date:  2003-02       Impact factor: 2.089

2.  Radiofrequency ablation of osteoid osteoma in atypical locations: a case series.

Authors:  Shahram Akhlaghpoor; Alireza Aziz Ahari; Abbas Arjmand Shabestari; Mohammad Reza Alinaghizadeh
Journal:  Clin Orthop Relat Res       Date:  2010-02-20       Impact factor: 4.176

3.  Symptomatic resolution of spinal osteoid osteoma with conservative management: imaging correlation.

Authors:  Prakash Jayakumar; S Harish; Colin Nnadi; Hilali Noordeen; Asif Saifuddin
Journal:  Skeletal Radiol       Date:  2006-09-12       Impact factor: 2.199

4.  Intraoperative localization of an osteoid-osteoma using a gamma probe.

Authors:  M Etchebehere; E C S C Etchebehere; L A Reganin; E M I Amstalden; A Cliquet; E E Camargo
Journal:  Int Orthop       Date:  2004-11-06       Impact factor: 3.075

5.  Case report: Osteoid osteoma of the acetabulum treated with arthroscopy-assisted radiofrequency ablation.

Authors:  Damiano Ricci; Guido Grappiolo; Matthew Franco; Federico Della Rocca
Journal:  Clin Orthop Relat Res       Date:  2013-01-12       Impact factor: 4.176

6.  Open resection of osteoid osteoma guided by a gamma-probe.

Authors:  Raphael Pratali; Guilherme Zuiani; Mauro Inada; Carlos Hanasilo; Luciano Reganin; Elba Etchebehere; Maurício Etchebehere
Journal:  Int Orthop       Date:  2008-05-14       Impact factor: 3.075

7.  An open-label, prospective, observational study of the efficacy of bisphosphonate therapy for painful osteoid osteoma.

Authors:  Valérie Bousson; Tifenn Leturcq; Hang-Korng Ea; Olivier Hauger; Nadia Mehsen-Cetre; Bassam Hamzé; Caroline Parlier-Cuau; Jean-Denis Laredo; Thierry Schaeverbeke; Philippe Orcel
Journal:  Eur Radiol       Date:  2017-09-07       Impact factor: 5.315

8.  Case report: late subtrochanteric fracture post radiofrequency ablation of osteoid osteoma.

Authors:  Enrico Bonicoli; Lorenzo Andreani; Nicola Piolanti; Veronica Zarra; Michele Lisanti
Journal:  Clin Cases Miner Bone Metab       Date:  2014-05

9.  Follow-up bone scintigraphy images of a patient with osteoid osteoma during medical treatment.

Authors:  Zehra Pinar Koç; Binnur Karayalcin
Journal:  BMJ Case Rep       Date:  2012-10-19

10.  [Osteoid osteoma of the talus: a rare cause for pain in the ankle joint].

Authors:  H Polzer; S Polzer; M Schieker; W Mutschler; M Regauer
Journal:  Unfallchirurg       Date:  2014-07       Impact factor: 1.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.